Invitrogen™ Kit ELISA AIF humain

Réf. : BL-RE-093668Réf. fabricant : EEL027 96 Tests
694,00 € HT

Apoptosis Inducing Factor (AIF) causes chromatin condensation and DNA fragmentation. AIF was recently identified, and cloned. Apoptosis is characterized by several morphological nuclear changes including chromatin condensation and nuclear…

Numéro d’adhésion
O95831
Plage de dosage
0.16 to 10 ng/mL
Sensibilité du dosage
0.1 ng/mL
Conjugué
HRP
Type de produit
ELISA
Marque
Invitrogen

Apoptosis Inducing Factor (AIF) causes chromatin condensation and DNA fragmentation. AIF was recently identified, and cloned. Apoptosis is characterized by several morphological nuclear changes including chromatin condensation and nuclear…

Apoptosis Inducing Factor (AIF) causes chromatin condensation and DNA fragmentation. AIF was recently identified, and cloned. Apoptosis is characterized by several morphological nuclear changes including chromatin condensation and nuclear fragmentation. These changes are triggered by the activation of members of caspase family, caspase activated DNase, and several novel proteins. Like the critical molecules, cytochrome c and caspase-9, in apoptosis, AIF localizes in mitochondria. AIF translocates to the nucleus when apoptosis is induced and induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. AIF induces chromatin condensation and large scale DNA fragmentation, which are the hallmarks of apoptosis, of the isolated nucleus and the nucleus in live cells by microinjection and apoptosis stimuli. AIF is highly conserved between human and mouse and widely expressed. Mutations in the AIF gene cause combined oxidative phosphorylation deficiency 6, which results in a severe mitochondrial encephalomyopathy. Alternative splicing results in multiple transcript variants of AIF and a related pseudogene has been identified on chromosome 10.

Sensibilité

Sensibilité du dosage : 0,1 ng/mL.

Plage de mesure

Plage de dosage : 0,16 à 10 ng/mL.

Durée du dosage

Durée totale du dosage : 3 h 30 min.

Échantillons

Type d’échantillon : Plasma (volume 100 µL).

Conjugué

Conjugué : HRP.

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)18077474
Caractéristiques
Numéro d’adhésionO95831
Plage de dosage0.16 to 10 ng/mL
Sensibilité du dosage0.1 ng/mL
ConjuguéHRP
Type de produitELISA
Type d’échantillonPlasma
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)9131
Symbole de gène(s)AIFM1
Coefficient de variation inter-dosage<10%
Coefficient de variation intra-dosage<10%
Contenus des kitsPre-coated 96 well plate, Standard, Biotinylated Detection Antibody, HRP Conjugate, Standard & Sample Diluent, Biotinylated Detection Antibody Diluent, HRP Conjugate Diluent, Wash Buffer, TMB Substrate, Stop Solution, Plate Sealer
Marqueur ou colorantHRP
Quantité96 Tests
État réglementaireRUO
CibleHuman
Heure du test1 hr 20 min
Caractéristiques physiques
Volume d’échantillon100 µL
Stockage et expédition
Conditions de stockageRefer to product documentation for component specific storage temperature.
Durée totale du dosage3 hr 30 min

Origine et douane

Réf. fabricantEEL027
Pays d’origineChine
Code douanier (SH)3822 11 00 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.